CDXS vs K · rev $59.3M vs P/E 23, $29.03B cap
Codexis Inc (CDXS) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Codexis Inc (CDXS) is a biotechnology company listed on US.
Kellanova (K) is a packaged foods company listed on US.
Latest reported CDXS revenue for 2024-12-31 was $59.3M. Net income was -$65.3M. Revenue was down 15.4% from 2023-12-31 to 2024-12-31. CDXS currently screens at market cap $257.6M.
K does not have a complete income-statement cache yet.
CDXS currently screens at market cap $257.6M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CDXS and K stock pages for the full models.
Not investment advice.